145 related articles for article (PubMed ID: 25257291)
1. Efficacy and safety of the glycine transporter-1 inhibitor org 25935 for the prevention of relapse in alcohol-dependent patients: a randomized, double-blind, placebo-controlled trial.
de Bejczy A; Nations KR; Szegedi A; Schoemaker J; Ruwe F; Söderpalm B
Alcohol Clin Exp Res; 2014 Sep; 38(9):2427-35. PubMed ID: 25257291
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the glycine transporter inhibitor Org 25935 as augmentation to cognitive-behavioral therapy for panic disorder: a multicenter, randomized, double-blind, placebo-controlled trial.
Nations KR; Smits JA; Tolin DF; Rothbaum BO; Hofmann SG; Tart CD; Lee A; Schipper J; Sjogren M; Xue D; Szegedi A; Otto MW
J Clin Psychiatry; 2012 May; 73(5):647-53. PubMed ID: 22394471
[TBL] [Abstract][Full Text] [Related]
3. The selective glycine uptake inhibitor org 25935 as an adjunctive treatment to atypical antipsychotics in predominant persistent negative symptoms of schizophrenia: results from the GIANT trial.
Schoemaker JH; Jansen WT; Schipper J; Szegedi A
J Clin Psychopharmacol; 2014 Apr; 34(2):190-8. PubMed ID: 24525661
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
[TBL] [Abstract][Full Text] [Related]
5. A pilot double-blind treatment trial of memantine for alcohol dependence.
Evans SM; Levin FR; Brooks DJ; Garawi F
Alcohol Clin Exp Res; 2007 May; 31(5):775-82. PubMed ID: 17378918
[TBL] [Abstract][Full Text] [Related]
6. The glycine reuptake inhibitor Org 25935 decreases ethanol intake and preference in male wistar rats.
Molander A; Lidö HH; Löf E; Ericson M; Söderpalm B
Alcohol Alcohol; 2007; 42(1):11-8. PubMed ID: 17098748
[TBL] [Abstract][Full Text] [Related]
7. Glycine transporter-1 blockade leads to persistently reduced relapse-like alcohol drinking in rats.
Vengeliene V; Leonardi-Essmann F; Sommer WH; Marston HM; Spanagel R
Biol Psychiatry; 2010 Oct; 68(8):704-11. PubMed ID: 20655511
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of levetiracetam for the prevention of alcohol relapse in recently detoxified alcohol-dependent patients: a randomized trial.
Richter C; Effenberger S; Bschor T; Bonnet U; Haasen C; Preuss UW; Heinz A; Förg A; Volkmar K; Glauner T; Schaefer M
J Clin Psychopharmacol; 2012 Aug; 32(4):558-62. PubMed ID: 22722516
[TBL] [Abstract][Full Text] [Related]
9. A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence.
Anton RF; Kranzler H; Breder C; Marcus RN; Carson WH; Han J
J Clin Psychopharmacol; 2008 Feb; 28(1):5-12. PubMed ID: 18204334
[TBL] [Abstract][Full Text] [Related]
10. Topiramate treatment for alcoholic outpatients recently receiving residential treatment programs: a 12-week, randomized, placebo-controlled trial.
Likhitsathian S; Uttawichai K; Booncharoen H; Wittayanookulluk A; Angkurawaranon C; Srisurapanont M
Drug Alcohol Depend; 2013 Dec; 133(2):440-6. PubMed ID: 23906999
[TBL] [Abstract][Full Text] [Related]
11. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial.
Johnson BA; Ait-Daoud N; Bowden CL; DiClemente CC; Roache JD; Lawson K; Javors MA; Ma JZ
Lancet; 2003 May; 361(9370):1677-85. PubMed ID: 12767733
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial.
Guardia J; Caso C; Arias F; Gual A; Sanahuja J; Ramírez M; Mengual I; Gonzalvo B; Segura L; Trujols J; Casas M
Alcohol Clin Exp Res; 2002 Sep; 26(9):1381-7. PubMed ID: 12351933
[TBL] [Abstract][Full Text] [Related]
13. Topiramate for treating alcohol dependence: a randomized controlled trial.
Johnson BA; Rosenthal N; Capece JA; Wiegand F; Mao L; Beyers K; McKay A; Ait-Daoud N; Anton RF; Ciraulo DA; Kranzler HR; Mann K; O'Malley SS; Swift RM; ;
JAMA; 2007 Oct; 298(14):1641-51. PubMed ID: 17925516
[TBL] [Abstract][Full Text] [Related]
14. Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial.
Johnson BA; Ait-Daoud N; Akhtar FZ; Ma JZ
Arch Gen Psychiatry; 2004 Sep; 61(9):905-12. PubMed ID: 15351769
[TBL] [Abstract][Full Text] [Related]
15. A phase 2, placebo-controlled study of the opioid receptor antagonist LY2196044 for the treatment of alcohol dependence.
Wong CJ; Witcher J; Mallinckrodt C; Dean RA; Anton RF; Chen Y; Fijal BA; Ouyang H; Dharia S; Sundseth SS; Schuh KJ; Kinon BJ
Alcohol Clin Exp Res; 2014 Feb; 38(2):511-20. PubMed ID: 24010675
[TBL] [Abstract][Full Text] [Related]
16. Amisulpride does not prevent relapse in primary alcohol dependence: results of a pilot randomized, placebo-controlled trial.
Marra D; Warot D; Berlin I; Hispard E; Notides C; Tilikete S; Payan C; Lépine JP; Dally S; Aubin HJ
Alcohol Clin Exp Res; 2002 Oct; 26(10):1545-52. PubMed ID: 12394288
[TBL] [Abstract][Full Text] [Related]
17. Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial.
Addolorato G; Leggio L; Ferrulli A; Cardone S; Bedogni G; Caputo F; Gasbarrini G; Landolfi R;
Alcohol Alcohol; 2011; 46(3):312-7. PubMed ID: 21414953
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, placebo-controlled, randomized pilot study comparing quetiapine with placebo, associated to naltrexone, in the treatment of alcohol-dependent patients.
Guardia J; Roncero C; Galan J; Gonzalvo B; Burguete T; Casas M
Addict Behav; 2011 Mar; 36(3):265-9. PubMed ID: 21146937
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid receptor 1 blocker rimonabant (SR 141716) for treatment of alcohol dependence: results from a placebo-controlled, double-blind trial.
Soyka M; Koller G; Schmidt P; Lesch OM; Leweke M; Fehr C; Gann H; Mann KF;
J Clin Psychopharmacol; 2008 Jun; 28(3):317-24. PubMed ID: 18480689
[TBL] [Abstract][Full Text] [Related]
20. [A double blind placebo controlled randomized clinical trial of the efficacy and safety of pregabalin in induction of remission in patients with alcohol dependence].
Krupitsky EM; Rybakova KV; Skurat EP; Semenova NV; Neznanov NG
Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(1):33-43. PubMed ID: 32105267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
